326 related articles for article (PubMed ID: 10549683)
1. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
3. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
Fava M; Asnis GM; Shrivastava R; Lydiard B; Bastani B; Sheehan D; Roth T
J Clin Psychopharmacol; 2009 Jun; 29(3):222-30. PubMed ID: 19440075
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
5. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
Krystal A; Fava M; Rubens R; Wessel T; Caron J; Wilson P; Roth T; McCall WV
J Clin Sleep Med; 2007 Feb; 3(1):48-55. PubMed ID: 17557453
[TBL] [Abstract][Full Text] [Related]
8. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
9. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
11. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
[TBL] [Abstract][Full Text] [Related]
12. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
Shaw SH; Curson H; Coquelin JP
J Int Med Res; 1992 Apr; 20(2):150-61. PubMed ID: 1521671
[TBL] [Abstract][Full Text] [Related]
15. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
Perlis ML; McCall WV; Krystal AD; Walsh JK
J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
[TBL] [Abstract][Full Text] [Related]
16. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
17. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
Roehrs TA; Roth T
J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
[TBL] [Abstract][Full Text] [Related]
18. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
Dockhorn RJ; Dockhorn DW
Clin Neuropharmacol; 1996 Aug; 19(4):333-40. PubMed ID: 8828996
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].
Guazzelli M; Ciapparelli A; Balsamo EL; Gemignani A; Sarteschi P
Minerva Psichiatr; 1993 Sep; 34(3):193-203. PubMed ID: 8302193
[TBL] [Abstract][Full Text] [Related]
20. Eight weeks of non-nightly use of zolpidem for primary insomnia.
Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
